Polygenic Risk Scores Show Utility for Stratifying Disease Risk
Polygenic Risk Scores Offer a Glimpse of True Clinical Utility
Cloning After Dolly
Besides Sheep and Cattle, Cat, Deer, Dog, Horse, Mule, Ox, Rabbit, Rat, and Monkey Have Been Cloned from Somatic Cells
Tumor Biomarkers Culled from Errant Transcripts
Potential for Blood Platelet–Derived Biomarkers to ID and Locate Tumors
Sequencing Within Reach
An Orthogonal Approach to Genome Sequencing
For full access to this article login to GEN Select now.
Quantifying Downstream Capacity Crunch
Column Resins Are Implicated by Many Experts As the Source of Biomanufacturing's Woes
- In today’s biomanufacturing environment, downstream capacity has become a partial roadblock to nearly all CMOs (94%) and more than half (61%) of biotherapeutic developers. Extensive data from 434 biopharmaceutical manufacturers in 32 countries is summarized in BioPlan Associates’ just-released 5th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.